"Medcan Australia (Medcan) is pleased to announce the
successful sales of 90% of its first shipment of imported Medcan Australia
branded products into the Australian market.
The first sale of Medcan Australia branded product into the Australian market is a significant milestone as it validates Medcan’s supply chain through to patient sales.
Successful first sales of Medcan Australia branded products:
- realizes Medcan’s vision of being able to supply more cost effective products to Australian patients
- validates Medcan’s short term revenue strategy with the import of Medcan Australia branded products into the Australian market
- commences Medcan’s strategic penetration into the Australian market with the Medcan Australia product brand
- allows an immediate additional revenue stream to support Medcan’s business development. For further information on Medcan’s expansion plans: https://www.bluemountcapital.com/MCG/
from Craig Cochran - CEO Medcan Australia:
Medcan Australia Founder, Craig Cochran said: “The first sales of our range of Medcan Australia branded products into the Australian market is one of our most significant milestones to date. It validates Medcan’s short term revenue strategy and is the start of Medcan’s strategic penetration into the Australian market. It sets a solid foundation for the Medcan Australia brand which will continue to be built on with the addition of further products and ultimately the transition to Australian produced Medcan products.”
Craig Continued: “Medcan’s vision has always been to provide reliable access to patient specific Medicinal Cannabis products at the most cost effective price. This is the first step on the way to realizing that vision.”"
Gareth Ball, Director, Medcan Group Pty Ltd, 19 November 2019.
Please read the full announcement via the link below.
For more information about Medcan please click here.